Natera

Partner Manager (US - East Coast)

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
AI & Machine Learning, Enterprise Software, ConsultingIndustries

Requirements

Candidates should have a proven track record in account management or business development, particularly with large consulting firms or enterprises. Strong experience in building relationships with C-Suite executives is essential, along with a strategic mindset to develop go-to-market strategies. A background in technology sales and familiarity with AI solutions will be advantageous.

Responsibilities

The Partner Manager will drive revenue growth by identifying and nurturing relationships with key strategic partners. They will manage a portfolio of large consulting firms and enterprises across the UK, US, and Europe, engaging with high-level executives to develop joint strategies. The role involves forming alliances, integrating solutions into partner offerings, and scaling technology usage within complex environments.

Skills

Relationship-building
Strategic thinking
Sales
Account management
Executive engagement
Strategic planning
Go-to-market strategy

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Key Metrics

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI